Quipt Home Medical Corp.
5.90%
2,547,884
1540013
74880P104
Jan 24, 2025
Jan 28, 2025, 03:35 PM
Reporting Persons (4)
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Kanen Wealth Management LLC | Investment Adviser | 5.90% | 2,544,084 | 0 | 2,544,084 |
| Kanen David | Individual | 5.90% | 2,547,884 | 3,800 | 2,544,084 |
| Philotimo Focused Growth & Income Fund | Investment Adviser | 3.80% | 1,655,011 | 0 | 1,655,011 |
| Philotimo Fund, LP | Investment Adviser | 1.90% | 801,854 | 0 | 801,854 |
Disclosure Items (6)
Common Shares, without Par Value
Quipt Home Medical Corp.
1019 TOWN DRIVE, WILDER, KY, 41076
Item 2(a) is hereby amended and restated to read as follows: This statement is filed by: (i) Philotimo Fund, LP, a Delaware limited partnership ("Philotimo"), with respect to the Shares directly and beneficially owned by it; (ii) Philotimo Focused Growth and Income Fund, a series of World Funds Trust, a Delaware statutory trust ("PHLOX"), with respect to the Shares directly and beneficially owned by it; (iii) Kanen Wealth Management, LLC, a Florida limited liability company ("KWM"), as the general partner of Philotimo, the investment manager of PHLOX and certain separately managed accounts (the "Managed Accounts"); and (iv) David L. Kanen, as the managing member of KWM. Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons." Each of the Reporting Persons is party to that certain Joint Filing Agreement, as further described in Item 6 of the Schedule 13D filed with the Securities Exchange Commission on January 10, 2025.
Item 3 is hereby amended and restated to read as follows: The Shares purchased by Philotimo were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The Shares purchased by PHLOX were purchased with the funds for the accounts of its customers (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The Shares purchased by KWM were purchased with the funds for the accounts of its customers (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The aggregate purchase price of the 801,854 Shares beneficially owned by Philotimo is approximately $2,178,768, including brokerage commissions. The aggregate purchase price of the 1,655,011 Shares beneficially owned by PHLOX is approximately $4,604,846, including brokerage commissions. The aggregate purchase price of the 87,219 Shares held in the Managed Accounts is approximately $258,091, including brokerage commissions. The aggregate purchase price of the 3,800 Shares beneficially owned by Mr. Kanen is approximately $11,246, including brokerage commissions.
Item 5(a) is hereby amended and restated to read as follows: The aggregate percentage of Shares reported owned by each person named herein is based upon 43,091,273 Shares outstanding as of January 16, 2025 as reported in the Issuer's Proxy Statement on Form DEF 14A filed with the SEC on January 24, 2025. A. Philotimo As of the close of business on January 28, 2025, Philotimo beneficially owned 801,854 Shares. Percentage: Approximately 1.9% B. PHLOX As of the close of business on January 28, 2025, PHLOX beneficially owned 1,655,011 Shares. Percentage: Approximately 3.8% C. KWM As of the close of business on January 28, 2025, KWM beneficially owned 2,544,084 Shares, consisting of (i) the 801,854 Shares owned directly by Philotimo, which KWM may be deemed to beneficially own as the general partner of Philotimo, (ii) the 1,655,011 Shares owned directly by PHLOX, which KWM may be deemed to beneficially own as the investment manager of PHLOX and (iii) 87,219 Shares held in the Managed Accounts. Percentage: Approximately 5.9% D. Mr. Kanen As of the close of business on January 28, 2025, Mr. Kanen may be deemed to beneficially own 2,547,884 Shares, consisting of (i) the 3,800 Shares owned directly by Mr. Kanen and (ii) the 2,544,084 Shares beneficially owned by KWM, which Mr. Kanen may be deemed to beneficially own as the managing member of KWM. Percentage: Approximately 5.9%.
Item 5(b) is hereby amended and restated to read as follows: A. Philotimo 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 801,854 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 801,854 B. PHLOX 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 1,655,011 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 1,655,011 C. KWM 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 2,544,084 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 2,544,084 D. Mr. Kanen 1. Sole power to vote or direct vote: 3,800 2. Shared power to vote or direct vote: 2,544,084 3. Sole power to dispose or direct the disposition: 3,800 4. Shared power to dispose or direct the disposition: 2,544,084
Item 5(c) is hereby amended and restated to read as follows: A. Philotimo The transactions in the Shares by Philotimo since the filing of the Schedule 13D are set forth in Exhibit 1 and are incorporated herein by reference. B. PHLOX PHLOX has not entered into transactions in the Shares since the filing of the Schedule 13D. C. KWM The transactions in the Shares by KWM since the filing of the Schedule 13D are set forth in Exhibit 1 and are incorporated herein by reference. D. Mr. Kanen The transactions in the Shares by Mr. Kanen since the filing of the Schedule 13D are set forth in Exhibit 1 and are incorporated herein by reference. KWM, in its role as investment manager to the Managed Accounts, to which it furnishes investment advice, and Mr. Kanen, as the managing member of KWM, may each be deemed to beneficially own shares of the Issuer's Shares held in the Managed Accounts.
1 - Transactions in Securities.